The global cardiac rhythm management, electrophysiology & cardiac ablation market is valued at approximately $17.5 billion in 2021 and is expected to grow at a CAGR of 4.9% to reach over $24 billion during the forecast period. The full report suite on this market covers various products such as pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters, and cardiac ablation catheters. With an increasing demand for advanced medical devices for the treatment of heart diseases, the market for cardiac rhythm management, electrophysiology & cardiac ablation is poised for steady growth in the coming years.
Medtronic has maintained a strong presence in the total market for cardiac rhythm management (CRM), electrophysiology (EP) and ablation through brand recognition, strong customer support and a large sales force.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET TRENDS
The cardiac rhythm management and ablation sector is rapidly evolving with new technologies emerging on a regular basis. In the last decade, there have been significant improvements in the capabilities and battery lifespan of pacemakers and ICDs. Over the forecast period, the adoption of wireless technology is expected to make it easier for doctors to monitor and adjust the functions of these devices. This will likely result in higher sales of pacemakers and ICDs, as well as maintain high selling prices due to the incorporation of advanced technologies. The continued development and integration of new technologies will be a key driver of growth in this market in the coming years.GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET SHARE INSIGHTS
The global cardiac rhythm management device market is dominated by three major players - Medtronic, Abbott, and Boston Scientific. Out of the more than 60 companies analyzed in this market, these three companies hold a significant market share and are recognized as the industry leaders.Medtronic has maintained a strong presence in the total market for cardiac rhythm management (CRM), electrophysiology (EP) and ablation through brand recognition, strong customer support and a large sales force.
MARKET SEGMENTATION SUMMARY
Pacemaker Market - Includes:- Single-Chamber Pacemaker, Dual-Chamber Pacemaker, and Leadless Pacemaker
- Implantable Cardioverter Defibrillator Market - Includes:
- Single-Chamber ICD, Dual-Chamber ICD, and S-ICDs
- Cardiac Resynchronization Therapy Device Market - Includes:
- CRT-P, CRT-D
- Cardiac Lead Market - Includes:
- Pacing Lead, Defibrillation Lead, and LV Lead
- Implant Loop Recorder Market
- Electrophysiology Lab System Market - Includes:
- 3D Mapping System, EP Recording System
- Diagnostic Electrophysiology Catheter Market - Includes:
- Conventional EP Catheter, Advanced EP Catheter, and ICE Catheter
- Cardiac Ablation Catheter Market - Includes:
- RF Ablation Catheter, Cryoablation Catheter
RESEARCH SCOPE SUMMARY
Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)- Base Year: 2021
- Forecast: 2021-2028
- Historical Data: 2018-2021
- Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
- Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.
Table of Contents
1 Executive Summary- Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
- Competitive Analysis
- Market Trends
- Market Developments
- Procedures Included
- Markets Included
- Regions Included
- Version History
- Research Methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
2.1 Introduction
2.2 Regional Profiles
2.3 Analysis By Market Segment
2.3.1 Worst Case Scenario
2.3.2 Base Case Scenario
2.3.3 Best Case Scenario
3 Disease Overview
3.1 Introduction
3.2 Types of Arrhythmias
3.2.11 Atrial Fibrillation
3.2.12 Bradycardia
3.2.13 Conduction Disorders
3.2.13.1 Bundle Branch Block
3.2.13.2 Heart Block
3.2.13.3 Long QT Syndrome (LQTS)
3.2.14 Premature Contractions: PACs and PVCs
3.2.15 Tachycardia
3.2.16 Ventricular Fibrillation
3.2.17 Other Rhythm Disorders
3.2.17.1 Adams-Stokes Disease
3.2.17.2 Atrial Fluttertrd
3.2.17.3 Sick Sinus syndrome
3.2.17.4 Sinus Arrhythmia
3.2.17.5 Wolff-Parkinson-White Syndrome (WPW)
3.2.18 Types of Arrhythmia in Children
3.3 Heart Failure
3.4 Cardiac Arrest
3.5 Patient Demographics
3.5.11 Atrial Fibrillation
3.5.12 Bradycardia
3.5.13 Conduction Disorders
3.5.14 Premature Contractions - PACs and PVCs
3.5.15 Tachycardia
3.5.16 Ventricular Fibrillation
3.5.17 Other Rhythm Disorders
3.5.18 COVID & Arrhythmias
3.5.19 Heart Failure and Cardiac Arrest
4 Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Pacemakers
4.2.2 Implantable Cardioverter Defibrillators (ICDs)
4.2.3 Cardiac Resynchronization Therapy (CRT) Devices
4.2.4 Cardiac Leads
4.2.5 Implantable Loop Recorders
4.2.6 Electrophysiology Lab Systems
4.2.6.1 Introduction
4.2.6.2 3D Mapping Systems
4.2.6.3 EP Recording Systems
4.2.6.4 Remote Steering Systems
4.2.6.5 RF Ablation Generator
4.2.6.6 ICE Systems
4.2.7 Diagnostic EP Catheters
4.2.7.1 Introduction
4.2.7.2 Diagnostic EP Catheters
4.2.7.3 ICE Catheters
4.2.8 Cardiac Ablation Catheters
4.2.8.1 Introduction
4.2.8.2 RF Ablation Catheters
4.2.8.3 Alternative Energy Catheters
4.2.8.4 High Intensity Focused Ultrasound
4.3 Regulatory Issues and Recalls
4.3.1 Abbott
4.3.1.1 Pacemakers
4.3.1.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.1.4 Cardiac Leads
4.3.1.5 EP Lab Devices
4.3.1.6 Cardiac Ablation Catheter
4.3.2 Biosense Webster
4.3.2.1 EP Lab Devices
4.3.2.2 Diagnostic EP Catheters
4.3.2.3 Cardiac Ablation Catheters
4.3.3 Boston Scientific
4.3.3.1 Pacemakers
4.3.3.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.3.4 Cardiac Leads
4.3.3.5 EP Lab Devices
4.3.3.6 RF Ablation Catheter
4.3.4 Medtronic
4.3.4.1 Pacemakers
4.3.4.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.4.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.4.4 Cardiac Leads
4.3.4.5 EP Lab Devices
4.3.5 MicroPort
4.3.5.1 Implantable Cardioverter Defibrillators (ICDs)
4.3.5.2 Cardiac Resynchronization Therapy (CRT) Devices
4.4 Clinical Trials
4.4.1 Pacemakers
4.4.2 Implantable Cardioverter Defibrillators (ICDs)
4.4.3 Cardiac Resynchronization Therapy (CRT) Devices
4.4.4 Cardiac Leads
4.4.5 Lab Systems
4.4.5.1 3D Mapping Systems
4.4.5.2 EP Recording Systems
4.4.5.3 RF Ablation Generators
4.4.5.4 ICE Systems
4.4.6 Diagnostic EP Catheters
4.4.6.1 Diagnostic Catheter
4.4.7 Cardiac Ablation Catheter
4.4.7.1 RF Ablation Catheters
4.4.7.2 Cryoablation Catheters
4.4.7.4 Laser Ablation Catheters
5 Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
5.1 Introduction
5.2 Market Overview & Trend Analysis
5.2.1 By Segment
5.2.2 By Region
5.3 Drivers and Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Competitive Market Share Analysis
5.5 Mergers and Acquisitions
5.6 Company Profiles
5.6.1 Abbott
5.6.2 Biosense Webster
5.6.3 Biotronik
5.6.4 Boston Scientific
5.6.5 GE Healthcare
5.6.6 Medtronic
5.6.7 MicroPort
5.7 SWOT Analysis
5.7.1 Abbott
5.7.2 Biosense Webster
5.7.3 Biotronik
5.7.4 Boston Scientific
5.7.5 GE Healthcare
5.7.6 Medtronic
5.7.7 MicroPort
6 Pacemaker Market
6.1 Executive Summary
6.1.1 Global Pacemaker Market Overview
6.1.2 Competitive Analysis
6.1.3 Procedures Included
6.1.4 Markets Included
6.1.5 Regions Included
6.2 Introduction
6.2.1 Single and Dual-Chamber Devices
6.2.2 MRI-Compatible Pacemaker
6.2.3 Leadless Pacemaker
6.2.4 Initial Placement and Replacement of Pacemakers
6.3 Procedure Numbers
6.3.1 Total Pacemaker Placement Procedures
6.3.2 Initial Placement Pacemaker Procedures
6.3.3 Replacement Pacemaker Procedures
6.4 Market Overview
6.4.1 By Segment
6.4.2 By Region
6.5 Market Analysis and Forecast
6.5.1 Total Pacemaker Market
6.5.2 Single-Chamber Pacemaker Market
6.5.2.1 Initial Placement Single-Chamber Pacemaker Market
6.5.2.2 Replacement Single-Chamber Pacemaker Market
6.5.3 Dual-Chamber Pacemaker Market
6.5.3.1 Initial Placement Dual-Chamber Pacemaker Market
6.5.3.2 Replacement Dual-Chamber Pacemaker Market
6.5.4 Leadless Pacemaker Market
6.5.4.1 Initial Placement Leadless Pacemaker Market
6.5.4.2 Replacement Leadless Pacemaker Market
6.6 Drivers and Limiters
6.6.1 Market Drivers
6.6.2 Market Limiters
6.7 Competitive Market Share Analysis
7 Implantable Cardioverter defibrillator Market
7.1 Executive Summary
7.1.1 Global Implantable Cardioverter Defibrillator Market Overview
7.1.2 Competitive Analysis
7.1.3 Procedures Included
7.1.4 Markets Included
7.1.5 Regions Included
7.2 Introduction
7.3 Procedure Numbers
7.3.1 Total ICD Placement Procedures
7.3.2 Initial Placement ICD Procedures
7.3.3 Replacement ICD Procedures
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Total ICD Market
7.5.2 Single-Chamber ICD Market
7.5.2.1 Initial Placement Single-Chamber ICD Market
7.5.2.2 Replacement Single-Chamber ICD Market
7.5.3 Dual-Chamber ICD Market
7.5.3.1 Initial Placement Dual-Chamber ICD Market
7.5.3.2 Replacement Dual-Chamber ICD Market
7.5.4 S-ICD Market
7.5.4.1 Initial Placement S-ICD Market
7.5.4.2 Replacement S-ICD Market
7.6 Drivers and Limiters
7.6.1 Market Drivers
7.6.2 Market Limiters
7.7 Competitive Market Share Analysis
8 Cardiac Resynchronization Therapy Device Market
8.1 Executive Summary
8.1.1 Global Cardiac Resynchronization Therapy Device Market Overview
8.1.2 Competitive Analysis
8.1.3 Procedures Included
8.1.4 Markets Included
8.1.5 Regions Included
8.2 Introduction
8.2.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
8.2.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
8.3 Procedure Numbers
8.3.1 Total CRT Placement Procedures
8.3.2 Initial Placement CRT Procedures
8.3.3 Replacement CRT Procedures
8.4 Market Overview
8.4.1 By Segment
8.4.2 By Region
8.5 Market Analysis and Forecast
8.5.1 Total CRT Device Market
8.5.2 CRT-P Market
8.5.2.1 Initial Placement CRT-P Market
8.5.2.2 Replacement CRT-P Market
8.5.3 CRT-D Market
8.5.3.1 Initial Placement CRT-D Market
8.5.3.2 Replacement CRT-D Market
8.6 Drivers and Limiters
8.6.1 Market Drivers
8.6.2 Market Limiters
8.7 Competitive Market Share Analysis
9 Cardiac Lead Market
9.1 Executive Summary
9.1.1 Global Cardiac Lead Market Overview
9.1.2 Competitive Analysis
9.1.3 Markets Included
9.1.4 Regions Included
9.2 Introduction
9.2.1 Replacement of Leads
9.3 Market Overview
9.3.1 By Segment
9.3.2 By Region
9.4 Market Analysis and Forecast
9.4.1 Total Cardiac Lead Market
9.4.2 Pacing Lead Market
9.4.3 Defibrillation Lead Market
9.4.4 LV Lead Market
9.5 Drivers and Limiters
9.5.1 Market Drivers
9.5.2 Market Limiters
9.6 Competitive Market Share Analysis
10 Implantable Loop Recorder Market
10.1 Executive Summary
10.1.1 Global Implantable Loop Recorder Market Overview
10.1.2 Competitive Analysis
10.1.3 Regions Included
10.2 Introduction
10.3 Procedure Numbers
10.4 Market Analysis and Forecast
10.5 Drivers and Limiters
10.5.1 Market Drivers
10.5.2 Market Limiters
10.6 Competitive Market Share Analysis
11 Electrophysiology Lab System Market
11.1 Executive Summary
11.1.1 Global Electrophysiology Lab System Market Overview
11.1.2 Competitive Analysis
11.1.3 Markets Included
11.1.4 Regions Included
11.2 Introduction
11.2.1 3D Mapping Systems
11.2.2 EP Recording Systems
11.3 Market Overview
11.3.1 By Segment
11.3.2 By Region
11.4 Market Analysis and Forecast
11.4.1 Total Electrophysiology Lab System Market
11.4.2 3D Mapping System Market
11.4.3 EP Recording System Market
11.5 Drivers and Limiters
11.5.1 Market Drivers
11.5.2 Market Limiters
11.6 Competitive Market Share Analysis
12 Diagnostic Electrophysiology Catheter Market
12.1 Executive Summary
12.1.1 Global Diagnostic Electrophysiology Catheter Market Overview
12.1.2 Competitive Analysis
12.1.3 Markets Included
12.1.4 Regions Included
12.2 Introduction
12.2.1 Diagnostic Electrophysiology Catheters
12.2.2 Intracardiac Echocardiography
12.3 Procedure Numbers
12.4 Market Overview
12.4.1 By Segment
12.4.2 By Region
12.5 Market Analysis and Forecast
12.5.1 Total Diagnostic Electrophysiology Catheter Market
12.5.2 Conventional Electrophysiology Catheter Market
12.5.3 Advanced Electrophysiology Catheter Market
12.5.4 ICE Catheter Market
12.6 Drivers and Limiters
12.6.1 Market Drivers
12.6.2 Market Limiters
12.7 Competitive Market Share Analysis
13 Cardiac Ablation Catheter Market
13.1 Executive Summary
13.1.1 Global Cardiac Ablation Catheter Market Overview
13.1.2 Competitive Analysis
13.1.3 Procedures Included
13.1.4 Markets Included
13.1.5 Regions Included
13.2 Introduction
13.3 Procedure Numbers
13.3.1 Total Cardiac Ablation Procedures
13.3.2 RF Ablation Procedures
13.3.3 Cryoablation Procedures
13.4 Market Overview
13.4.1 By Segment
13.4.2 By Region
13.5 Market Analysis and Forecast
13.5.1 Total Cardiac Ablation Catheter Market
13.5.2 RF Ablation Catheter Market
13.5.3 Cryoablation Catheter Market
13.6 Drivers and Limiters
13.6.1 Market Drivers
13.6.2 Market Limiters
13.7 Competitive Market Share Analysis
14 Abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- Lepu Medical
- Angel Medical Systems
- Medico
- AngioDynamics
- Medtronic
- AtriCure
- MicroPort
- Biosense Webster
- Pacetronix
- Biotronik
- Philips
- Boston Scientific
- Schwarzer Cardiotek
- CathVision
- Siemens
- GE Healthcare
- Stereotaxis
- Imricor Medical Systems
- Vectorious
- JJET
